AGLagilon health, inc.
Is the business good?
Margins steady. That is the only one of 4 checks this filer's data supports, so take it as a single data point rather than a settled answer.
Margins have held roughly steady, a stable cost structure.
Where this answer is blind. The F-score rewards improvement, so an already-elite company can score mid-pack.
How good a business is AGL?
agilon health, inc. keeps −5.2% of every revenue dollar as operating profit, against 9.3% for the median Medical Care Facilities name.
Operating margin · Medical Care Facilities median 9.3% · 12 months to Q2 2026
- Share count, year on year
- +4.0%
Share count, year on year · shareholders own a smaller slice than a year ago
| Year | Operating margin |
|---|---|
| FY2020 | −4.7% |
| FY2021 | −24% |
| FY2022 | −4.4% |
| FY2023 | −5.4% |
| FY2024 | −4.8% |
| FY2025 | −7.8% |
Details›
- Operating margin12 months to Q2 2026
- −5.2%
- Net margin12 months to Q2 2026
- −3.9%
- Free cash flow margin
- −1.4%
- Revenue, trailing twelve months
- $5.92B
- Free cash flow, trailing twelve months
- −$85M
- Net income, trailing twelve months
- −$232M
Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.
Customers and suppliers
Who buys from AGL and who it buys from, as the companies report it.
- Payor A17%
Share of revenue · FY2025 10-K
- Payor B16%
Share of revenue · FY2025 10-K
- Payor C13%
Share of revenue · FY2025 10-K
- Payor E10%
Share of revenue · FY2025 10-K
None disclosed.
A company has to disclose every customer behind 10% or more of its revenue. Each share comes from the latest annual report of the company that states it and shows on both companies’ pages; AGL’s own figures are from its FY2025 10-K. Smaller customers and suppliers go unreported.